Torsten Diesinger

3PUBLICATIONS
0CO-AUTHORS
Biologically active moleculesMolecular targetsChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 26, 2021
ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.

Torsten Diesinger, Alfred Lautwein, Vyacheslav Buko

|Feb 19, 2021
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.

Torsten Diesinger, Alfred Lautwein, Sebastian Bergler

|Jul 24, 2020
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.

Torsten Diesinger, Vyacheslav Buko, Alfred Lautwein

Pageof 1

Frequent Collaborators